BackReneo Pharmaceuticals Overview
Reneo Pharmaceuticals Inc

Reneo Pharmaceuticals Discounted Cash Flow

DCF Analysis for RPHM.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$0.87

Current Fair Value

$0.87
95.2% Downside

Overvalued by 95.2% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading